STANOZOLOL is an oral androgen derived from dihydrotestosterone. Stanozolol 10 acts on androgen receptors to promote anabolism through increased nitrogen retention and protein synthesis in muscle tissue. Stanozolol 10 is a strong anabolic substance with androgenic action. Stanozolol does not convert to estrogen and therefore does not produce typical estrogen mediated side effects such as water retention. Stanozolol has a large oral bioavailability, due to a C17 a-alkylation which allows the hormone to survive first pass liver metabolism. Stanozolol reduces SHBG increasing free testosterone levels
Superdrol is an AAS comprised of the active steroidal hormone Methyldrostanolone. This is a dihydrotestosterone (DHT) derived anabolic steroid or more specifically a structurally altered form of Drostanolone. Superdrol is simply the Drostanolone hormone with an added methyl group at the 17th carbon position that allows the hormone to survive oral ingestion and officially classifies it as a C17-alpha alkylated (C17-aa) anabolic steroid. It also carries an added methyl group at the carbon two position, which greatly increases its anabolic power. These slight alterations will also reduce Superdrol’s androgenicity compared to Masteron, which isn’t all thatandrogenic to begin with.